BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7873379)

  • 1. Efficacy of an analysis of lymphocyte subsets in predicting the clinical response to alpha-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study.
    Russo-Mancuso G; Di Gregorio F; Passero E; Sciotto A; Mazzarino MC; Malaponte G; Schilirò G
    Br J Haematol; 1995 Feb; 89(2):291-8. PubMed ID: 7873379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alpha-interferon on natural killer cell activity and lymphocyte subsets in thalassemia patients with chronic hepatitis C.
    Malaponte G; Passero E; Leonardi S; Monte V; Lauria C; Mazzarino C; Sciotto A; Russo Mancuso G; Di Gregorio F; Musumeci S
    Acta Haematol; 1997; 98(2):83-8. PubMed ID: 9286304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant alpha-2b-interferon may restore natural-killer activity in patients with B-chronic lymphocytic leukemia.
    Villamor N; Reverter JC; Montserrat E; Urbano-Ispízua A; Vives-Corrons JL; Rozman C
    Leukemia; 1992 Jun; 6(6):547-52. PubMed ID: 1376376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Cell Subsets Evaluation as a Predictive Tool for Hepatitis B Infection Outcome and Treatment Responsiveness.
    Kandilarova SM; Georgieva AI; Mihaylova AP; Baleva MP; Atanasova VK; Petrova DV; Popov GT; Naumova EJ
    Folia Med (Plovdiv); 2017 Mar; 59(1):53-62. PubMed ID: 28384114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha interferon treatment of chronic hepatitis C in beta-thalassaemia.
    Di Marco V; Lo Iacono O; Capra M; Grutta S; Ciaccio C; Gerardi C; Maggio A; Renda D; Almasio P; Pisa R
    Gut; 1993; 34(2 Suppl):S142-3. PubMed ID: 8314484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood lymphocyte subsets in patients with chronic hepatitis C--effects of interferon treatment.
    Wejstål R; Norkrans G; Lenkei R; Weiland O; Schvarcz R; Frydén A
    Liver; 1992 Aug; 12(4 Pt 1):161-7. PubMed ID: 1406078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological response in chronic hepatitis C virus infection during interferon alpha therapy.
    Panasiuk A; Prokopowicz D; Zak J
    Hepatogastroenterology; 2004; 51(58):1088-92. PubMed ID: 15239252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant alpha 2B interferon (IFN) in the treatment of chronic hepatitis C disease in thalassaemia major (TM).
    Wonke B; Donohue SM; Hoffbrand AV; Scheuer PJ; Brown D; Dusheiko G
    Bone Marrow Transplant; 1993; 12 Suppl 1():24-5. PubMed ID: 8397033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-lymphocyte subpopulations as factors predicting clinical response to interferon in hepatitis C virus-related chronic active hepatitis.
    Guadagnino V; Caroleo B; Izzi A; De Rosa G; D'Amelio R
    Infection; 1995; 23(3):189-90. PubMed ID: 7499011
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment.
    Wejstål R; Norkrans G; Weiland O; Schvarcz R; Fuchs D; Wachter H; Fryden A; Glaumann H
    Clin Exp Immunol; 1992 Mar; 87(3):340-5. PubMed ID: 1544220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of therapy with interferon-alpha on peripheral blood lymphocyte subsets and NK activity in patients with chronic hepatitis C.
    Appasamy R; Bryant J; Hassanein T; Van Thiel DH; Whiteside TL
    Clin Immunol Immunopathol; 1994 Dec; 73(3):350-7. PubMed ID: 7955564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between LeY antigen and the therapeutic efficacy of interferon in chronic hepatitis C.
    Sata M; Nakano H; Hino T; Kosedo T; Adachi M; Tanikawa K
    Arch Virol Suppl; 1993; 8():265-9. PubMed ID: 7903177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Interferon treatment of chronic hepatitis C in young patients with homozygous beta-thalassemia.
    Di Marco V; Lo Iacono O; Capra M; Grutta S; Ciaccio C; Gerardi C; Maggio A; Renda D; Almasio P; Pisa R
    Haematologica; 1992; 77(6):502-6. PubMed ID: 1289187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Subpopulation blood lymphocyte composition in blood of patients with chronic hepatitis C during therapy with interferon].
    Mammaev SN
    Klin Lab Diagn; 2002 Jul; (7):15-8. PubMed ID: 12187585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha interferon in the treatment of chronic hepatitis C infection in thalassaemia major.
    Donohue SM; Wonke B; Hoffbrand AV; Reittie J; Ganeshaguru K; Scheuer PJ; Brown D; Dusheiko G
    Br J Haematol; 1993 Mar; 83(3):491-7. PubMed ID: 8387324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating T follicular helper cells are associated with rapid virological response in chronic hepatitis C patients undergoing peginterferon therapy.
    Zhang M; Zhang L; Li H; Chen Z; Luo A; Liu B; Chen M; Peng M; Ren H; Hu P
    Int Immunopharmacol; 2016 May; 34():235-243. PubMed ID: 26971227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy.
    Arizcorreta A; Márquez M; Fernández-Gutiérrez C; Guzmán EP; Brun F; Rodríguez-Iglesias M; Girón-González JA
    Clin Exp Immunol; 2006 Nov; 146(2):270-7. PubMed ID: 17034579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of lymphocyte subsets in a renal allograft recipient infected with human immunodeficiency virus.
    Hirano A; Yasukawa S; Ohkawa T; Takenaka T; Maeda J; Ooshima A
    Br J Urol; 1994 Sep; 74(3):283-7. PubMed ID: 7953255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of CD81 expression on lymphocyte subsets during interferon-alpha-based antiviral treatment of patients with chronic hepatitis C.
    Kronenberger B; Herrmann E; Hofmann WP; Wedemeyer H; Sester M; Mihm U; Ghaliai T; Zeuzem S; Sarrazin C
    J Leukoc Biol; 2006 Aug; 80(2):298-308. PubMed ID: 16735696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic mononuclear cell populations and MHC antigen expression in patients with chronic hepatitis C [correction of B]: effect of interferon-alpha.
    Van Thiel DH; Zhang X; Baddour N; Wright HI; Friedlander L; Gavaler JS
    Dig Dis Sci; 1994 May; 39(5):970-6. PubMed ID: 8174438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.